Cargando…
Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
BACKGROUND: Selection of specific patient-reported outcomes (PROs) for cancer patients requires careful consideration to the purpose and population at aim. Here we report the process of choosing which items to include in a bladder cancer population in chemo- or immunotherapy based on the Patient-Rep...
Autores principales: | Taarnhøj, Gry Assam, Lindberg, Henriette, Johansen, Christoffer, Pappot, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706489/ https://www.ncbi.nlm.nih.gov/pubmed/31440865 http://dx.doi.org/10.1186/s41687-019-0141-2 |
Ejemplares similares
-
Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience
por: Taarnhøj, Gry Assam, et al.
Publicado: (2021) -
Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
por: Taarnhøj, Gry A., et al.
Publicado: (2020) -
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
por: Taarnhøj, Gry Assam, et al.
Publicado: (2020) -
The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial
por: Taarnhøj, Gry Assam, et al.
Publicado: (2023) -
Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study
por: Rasmussen, Ida Marie Lind, et al.
Publicado: (2022)